Abstract
A commonly used tumor classification is essential in order to plan initial treatment, determine prognosis, assess treatment response, compare outcomes, and plan clinical trials. Berman maintains that for tumor classifications to be successful, they must reflect clinical reality and must be changed as information is accrued. Almost never does the staging of the tumor rest solely with the subspecialty surgeon. It usually results from interaction between pathologists and oncologists. In almost all solid childhood malignancies, except retinoblastoma, survival of the patient is the sole end point against which to assess treatment efficacy and side effects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fleming I. Staging of pediatric cancers: problems in the development of a national system. Semin Surg Oncol. 1992;8(2):94–7.
Berman JJ. Tumor classification: molecular analysis meets Aristotle. BMC Cancer. 2004;4:10.
Reese A, Ellsworth R. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164–72.
Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc. 1969;67:462–534.
Pratt CB, Fontanesi J, Lu X, et al. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist. 1997;2(1):1–5.
AJCC. Retinoblastoma. 6th ed. New York: Springer; 2002.
Wolff J, Boesel C, Ellsworth R. Extraocular retinoblastoma. Childrens Cancer Study Group Protocol CCSG 962. 1978.
Grabowski E, Abramson DH. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin N Am. 1978;1:721–35.
Stannard C, Sealy R, Hering E, et al. Postenucleation orbits in retinoblastoma: treatment with 125I brachytherapy. Int J Radiat Oncol Biol Phys. 2002;54(5):1446–54.
Kivela T, Kujala E. Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond. Eye (Lond). 2013;27(2):243–52.
Chantada G, Doz F, Antoneli CB, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47(6):801–5.
Chantada GL, Sampor C, Bosaleh A, et al. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients. JAMA Ophthalmol. 2013;131(9):1127–34.
Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133(8):1199–202.
de Graaf P, Goricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42(1):2–14.
Murphree AL. The case for a new group classification of intraocular retinoblastoma. Ophthalmol Clin North Am. 2005;18:41–53.
Novetsky DE, Abramson DH, Kim JW, Dunkel IJ. Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies – an analysis of impact. Ophthalmic Genet. 2009;30(1):40–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Murphree, A.L., Chantada, G.L. (2015). Retinoblastoma: Staging and Grouping. In: Singh, A., Murphree, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43451-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-43451-2_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43450-5
Online ISBN: 978-3-662-43451-2
eBook Packages: MedicineMedicine (R0)